Navigation Links
PharmAthene Reports First Quarter 2008 Financial Results
Date:5/13/2008

ANNAPOLIS, Md., May 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial results for the first quarter ended March 31, 2008.

"The first quarter was a particularly productive and exciting time for our Company. With the acquisition of Avecia's biodefense vaccines portfolio, completed on April 2, 2008, PharmAthene made substantial progress advancing our mission of becoming a premier biodefense company with industry-leading capabilities and a diversified portfolio of best-in-class, next generation products," commented David P. Wright, President and Chief Executive Officer.

"We have sought first to understand the needs of our customer -- the government, and then identify and acquire the very best products to meet those requirements. By adhering to this strategy we have built a diversified biodefense portfolio that includes novel, next generation rPA anthrax vaccines, an anthrax anti-toxin, Valortim(TM), a chemical nerve agent bioscavenger, Protexia(R), and a novel dual antigen plague vaccine. Many of these programs are poised to achieve important milestones this year, which have the potential to create significant value for our stockholders," said Mr. Wright.

In 2008, PharmAthene expects to:

-- Submit a response to a Request for Proposals (RFP) issued by the

Department of Health and Human Services (DHHS) for procurement

consideration of PharmAthene's second generation rPA anthrax vaccine.

The RFP has a requirement to procure 25 million doses of rPA anthrax

vaccine.

-- File an Investigational New Drug Application for Protexia(R), and

c
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
2. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
3. PharmAthene Reports Year-End 2007 Financial Results
4. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
5. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
6. PharmAthene to Delay Release of Full Year 2007 Financial Results
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. PharmAthene to Present at the BIO CEO & Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Sunnyvale, CA (PRWEB) July 22, 2014 ... begin on September 9th, 2014 and will comprise of ... and Application’ classes. The TechTrainings is a series of ... professionals, designed to help them reach the next step ... SAS class is taught by Jennifer Kang, Senior ...
(Date:7/21/2014)... Vernon Hills, IL (PRWEB) July 21, 2014 ... remote control, and simple programming, the new ... Pump Head is easy to operate for ... between cycles for hands-free dispensing. The batch count ... the cumulative volume or totalizer tracks amount dispensed ...
(Date:7/21/2014)... yield so far is small, but chemists at the ... substitution process to make a precursor to transparent thin ... energy devices. , A paper describing the approach is ... of the journal Inorganic Chemistry , which draws ... nuclear chemistry fields. The paper was chosen by the ...
(Date:7/21/2014)... Sleep disturbances such as insomnia, hypersomnia, ... depression. According to a study published by the ... of depressed patients have insomnia symptoms, and hypersomnia ... adults and 10% of older patients, with a ... have a major impact on quality of life, ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Oregon chemists eye improved thin films with metal substitution 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3
... — As a former attorney and current managing director ... certainly has tackled his share of challenges. But the ... its Public Advisory Committee, for which he recently began ... intimidated. , ,"I have to tell you, it's a ...
... Morlino has been elected chairman of the board of ... as stem-cell research. , , Morlino told The Capital ... human embryo is always morally wrong, and that research ... stem-cell research involves taking the cells initially from embryos, ...
... for a month-long series of events at the University ... in the Engineering Centers Building on April ... and three "science spectaculars", all free, non-ticketed, and open ... ,"It's a big sort of circus of science, basically," ...
Cached Biology Technology:Gulbrandsen tackles 'daunting' challenges in Patent Office 2Madison bishop with stem-cell views elected to national ethics group 2UW show to give public a go at cutting-edge science 2
(Date:7/22/2014)... recent scientific discovery showed that mutations in prickle ... brain disorder characterized by repeated seizures over time. ... was unknown. , A new University of Iowa ... Proceedings of the National Academy of Sciences , ... epilepsy. UI researchers have identified the basic cellular ...
(Date:7/22/2014)... The Carlton Complex fires started on July 14, 2014, by ... Valley. The Carlton Complex consists of four fires: Stokes Fire, ... The Stokes and Gold Hikes fires are now one larger ... the area burning is currently over 243,000 acres in size. ... to the high fire danger. Public and firefighter safety is ...
(Date:7/22/2014)... known as the ,1000 Bull Genomes Project, aims to ... cattle while also improving animal health and welfare. Results ... the whole genomes of 234 individual bulls whose direct ... reported in the journal Nature Genetics . , ... information to reduce or eliminate hereditary diseases and to ...
Breaking Biology News(10 mins):UI study finds potential genetic link between epilepsy and neurodegenerative disorders 2Whole-genome sequencing of bulls in key beef and dairy breeds 2
... Researchers at Delft University of Technology and the ... provides a unique test and measurement platform for the ... the journal Nature Nanotechnology (June 19 - ... with key proteins which mimicks the natural nuclear pore. ...
... pointed to a collection of test tubes in her Iowa ... like they were holding very weak coffee. That meant microorganisms ... biochemically converting sugars into hydrocarbons, said Jarboe, an Iowa State ... of the sugars in those test tubes were produced by ...
... prolonged snowfall can bring about unexpected conditions that encourage fungal ... according to experts. A new international study confirms that ... grow bigger, heavy and prolonged snow can, in certain circumstances, ... strains. The research results, published in the journal ...
Cached Biology News:Mimicking nature at the nanoscale: Selective transport across a biomimetic nanopore 2Iowa State hybrid lab combines technologies to make biorenewable fuels and products 2Iowa State hybrid lab combines technologies to make biorenewable fuels and products 3Arctic snow harbors deadly assassin 2
... is an evolutionarily conserved form of cell ... The central component of this process ... caspases. These enzymes participate in a ... response to pro-apoptotic signals and result in ...
... DNA Visualizer Extraction Kit is manufactured for ... DNA damage byexposure to UV light. The ... is often used for DNA-cloning work. The ... bromide and exposure of UV light damages ...
... TargeTron(TM) Gene Knockout System provides optimized reagents ... disruption of bacterial genes by insertion of ... retrohoming ability of group II introns and ... the TargeTron group II intron for specific ...
Mouse monoclonal antibody raised against a partial recombinant VRK2. NCBI Entrez Gene ID = VRK2...
Biology Products: